Retrospective study reports reduced rates of severe oral mucositis in stem cell transplant recipients, indicating improvements in managing treatment-induced mucosal toxicity.
While the incidence of oral mucositis in patients undergoing hematopoietic stem cell transplantation in our study was similar to be similar with the reported findings in the literature, the proportions of Grade 3 and 4 oral mucositis were lower in our study.
No takes yet. Share an insight, caveat, or question.
Kara et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: